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ABSTRACT
Background
Antigenemia is commonly detected in rotavirus-infected children. Although rotavirus RNA
has been detected in serum, definitive proof of rotavirus viremia has not been shown. We
aimed to analyze a defined patient population to determine if infectious virus could be
detected in sera from children with rotavirus antigenemia.
Methods and Findings
Serum samples obtained upon hospitalization from children with gastroenteritis (57 stool
rotavirus-positive and 41 rotavirus-negative), children with diagnosed bronchiolitis of known (n
¼58) or unknown (n¼17) viral etiology, children with noninfectious, nonchronic conditions (n
¼ 17), and healthy adults (n ¼ 28) were tested for rotavirus antigen by enzyme immunoassay
(EIA). Results of serum antigen testing were assessed for association with clinical and
immunological attributes of the children. Rotavirus antigenemia was detected in 90% (51/57) of
children with rotavirus-positive stools, in 89% (8/9) of children without diarrhea but with
rotavirus-positive stools, in 12% (2/17) of children with bronchiolitis of unknown etiology
without gastroenteritis, and in 12% (5/41) of children with gastroenteritis but with rotavirus-
negative stools. Antigenemia was not detected in sera from children with noninfectious
nonchronic conditions, children with bronchiolitis of known etiology and no gastroenteritis, or
healthy adults. Neither age nor timing of serum collection within eight days after onset of
gastroenteritis significantly affected levels of antigenemia, and there was no correlation
between antigenemia and viral genotype. However, there was a negative correlation between
serum rotavirus antigen and acute rotavirus-specific serum IgA (r¼ 0.44, p¼0.025) and IgG (r
¼  0.40, p ¼ 0.01) titers. We examined 11 antigen-positive and nine antigen-negative sera for
infectious virus after three blind serial passages in HT-29 cells using immunofluorescence
staining for rotavirus structural and nonstructural proteins. Infectious virus was detected in 11/
11 (100%) sera from serum antigen-positive children and in two out of nine (22%) sera samples
from antigen-negative children (p ¼ 0.002).
Conclusions
Most children infected with rotavirus are viremic. The presence of viremia is directly related
to the detection of antigenemia and is independent of the presence of diarrhea. Antigenemia
load is inversely related to the titer of antirotavirus antibody in the serum. The finding of
infectious rotavirus in the blood suggests extraintestinal involvement in rotavirus pathogenesis;
however, the impact of rotavirus viremia on clinical manifestations of infection is unknown.
The Editors’ Summary of this article follows the references.
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Rotavirus is a major cause of gastroenteritis in pediatric
populations, resulting in 114 million episodes of gastro-
enteritis per year worldwide [1] and an annual economic
burden in the United States estimated in 1998 at over one
billion dollars [2]. Rotaviral infection is generally thought to
be localized to the epithelial cells lining the small intestine.
However, case reports suggest that rotavirus may cause
infection and illness outside the intestine, including hepatitis
and nephritis [3], pneumonia [4], exanthema [5], disseminated
intravascular coagulation [6], haemophagocytic lymphohis-
tiocytosis [7], and neurological complications such as ence-
phalitis [8], encephalopathy [7], cerebellitis [9], or convulsions
or seizures [10,11]. Reports of attempts to ﬁnd rotavirus RNA
or proteins at extraintestinal sites include detection of RNA
in cerebral spinal ﬂuid [12,13], central nervous system [14],
heart [14,15], blood [16], and endothelial cells [14,17], while
rotavirus nonstructural proteins were detected in liver and
kidney sections [3]. These ﬁndings support the possibility of
uncommon extraintestinal infections that were thought to be
either infections with unusual rotavirus strains or rare host
genetic or immunologic defects in the infected child. Early
work supporting this idea described rotavirus antigenemia in
immunodeﬁcient but not immune-competent children [18].
Contrary to the general assumption that rotavirus remains
conﬁned to the intestine during infection, rotavirus anti-
genemia was reported in 67% of immunocompetent children
with rotavirus diarrhea [19], 43% of sera from Jamaican
children during a gastroenteritis outbreak [20], and acute
phase sera from ﬁve of eight children experiencing central
nervous system complications [21] with rotavirus gastro-
enteritis. The ability to detect rotavirus antigenemia is
inﬂuenced by factors such as increased acute-phase serum
IgG antibody titer [20], days after onset of diarrhea [19,20],
and stool viral antigen levels [20]. Although these studies
indicate that rotavirus antigenemia is common, they used
small or undeﬁned patient and control populations and
archived specimens. More comprehensive studies with well-
deﬁned patient populations are necessary to better under-
stand the host and viral factors that inﬂuence the extra-
intestinal spread of rotavirus. Here, we report examination of
samples from a prospective case-surveillance study and a
prospective cohort study to deﬁne some of the clinical and
immunological parameters that inﬂuence rotavirus antigene-
mia.
Rotavirus RNA is present in both extraintestinal tissues and
blood from children with rotavirus diarrhea [16,19,20,22].
Detection rates of extraintestinal RNA in blood have varied
widely, ranging from 0%–64% in rotavirus-infected children
and are not always concordant with presence of antigenemia
detected by enzyme immunoassay (EIA) [20,23,24]. Further-
more, the presence of RNA may not always be indicative of
infectious virus. Proof that rotavirus antigenemia or the
detection of RNA in the sera reﬂects infectious virus in the
sera (viremia) of infected children has not been reported.
Viremia has been detected in rotavirus-infected animals,
including mice, rats, and piglets [25]. Direct cultivation of
primary stool isolates of human rotaviruses in animals or
tissue culture cells is not routinely successful, and cultivation
from serum poses additional challenges. We utilized an
ampliﬁcation approach and adaptation in cell culture to
investigate whether rotavirus antigen-positive serum samples
from children contain infectious rotavirus.
Methods
Enrollment, Sample Collection, and Informed Consent
We examined antigenemia in ﬁve patient groups in three
separate studies. Study 1 included children from active
surveillance efforts to identify rotavirus-positive and
-negative children, and hospitalized matched controls with
noninfectious nonchronic conditions. Study 2 included
healthy adult laboratory workers. Study 3 included children
with bronchiolitis in which a viral agent could not be isolated
from a nasal wash specimen, and as a control group, children
with virus-associated bronchiolitis determined by isolation of
a virus from nasal washes by tissue culture.
Study 1: Children from active surveillance to identify
rotavirus positive and negative children. Serum and stool
samples collected from November 1997 through December
1999 during an active, prospective case-surveillance study at
three free-standing pediatric hospitals in the United States
[26,27] were analyzed. Criteria for eligibility in this study were
acute illness of less than 7 d duration characterized by
diarrhea, vomiting without a respiratory or structural gastro-
intestinal tract cause, and/or fever of unknown cause. Fever
was a criterion for inclusion in the active surveillance study
but not a criterion for inclusion in this study. Diarrhea was
deﬁned as an episode of three or more stools in a 24-h period
judged by the caregiver to be looser than normal. Vomiting
was deﬁned as the forceful expulsion of gastric contents
occurring at least once in a 24-h period. Fever was deﬁned as
a rectal temperature of .38.0 8C. After informed consent was
obtained, the parent or caregiver was interviewed to obtain
information regarding the symptoms of the child’s illness,
medical history, and demographic information.
As a comparison group for children in study 1 hospitalized
with gastroenteritis, a set of serum samples was obtained from
an age-matched population that included children hospital-
ized for noninfectious, nonchronic conditions. These samples
were collected during the same time period and at the same
sites as samples collected from children with gastroenteritis.
Study 2: Healthy adult laboratory workers. Sera from adult
laboratory workers without gastroenteritis were obtained.
Study 3: Children with bronchiolitis. Sera collected during
a prospective cohort study of children less than 24 mo of age
who presented to the emergency department between
November 2004 and February 2005 at Texas Children’s
Hospital, Houston, Texas, United States with signs and
symptoms of bronchiolitis (lower airway disease with tachyp-
nea, crackles, wheezing, or retractions), combined with a
history of preceding upper airway infection (nasal congestion
or rhinorrhea), were also examined. Sera collection over-
lapped with rotavirus season in Houston. Nasal washes
collected from these children were analyzed for the presence
of respiratory viruses, which included inﬂuenza A or B,
human metapneumovirus, respiratory syncytial virus, para-
inﬂuenza viruses, picornoviruses, and adenoviruses as de-
scribed (B. L. Bennett, S. G. Cron, R. L. Atmar, P. A. Piedra
unpublished data).
Informed consent was obtained from parents or guardians
of children enrolled in the study. The Institutional Review
Boards at each site approved each study.
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Stool (active, prospective case surveillance) and serum
(active, prospective case surveillance and bronchiolitis study)
specimens were collected at enrollment (within 24 h of
admission) and stored at 4 8C and  70 8C, respectively, until
testing. Stool specimens were tested for rotavirus antigen
using a commercial EIA (Rotaclone, Meridian Bioscience,
http://www.meridianbioscience.com). If the study participant’s
stool tested rotavirus-negative and an acute serum had been
obtained, a convalescent blood sample was solicited. The
concentration of rotaviral antigen in sera was estimated by
EIA as previously described, with the following modiﬁcations
[28]: 96-well polyvinylchloride plates were coated with 50 llo f
a mouse monoclonal anti-VP6 antibody (6E7, raised against
rotavirus strain SA11) overnight at room temperature. 6E7 is
broadly cross-reactive, recognizing many different strains of
animal and human rotavirus, including ECwt (P[19]G3,
murine), EDIM (P[18]G3, murine), RRV (P[3]G3, rhesus),
SA11 (P[2]G3, simian), ALA (P[14]G3, lapine), HAL1166
(P[14]G8, human), Wa (P[8]G1, human), PA169 (P[14]G6,
human), Ito (P[8]G3, human), and Hochi (P[8]G4, human)
(unpublished data). Wells were blocked with 200 llo f5 %
Carnation instant milk in PBS (blotto) for 2 h at 37 8C. Serum
samples were diluted 1:10 in TNC (10 mM Tris [pH 7.4], 140
mM NaCl, 10 mM CaCl2) to a total volume of 50 ll. Samples
were treated for 10 min at room temperature with 25 mM
EDTA. Hyperimmune guinea pig antiserum to rotavirus
(strain ALA) diluted in 0.5% blotto was used as a detector
antibody followed by HRP-conjugated goat anti-guinea pig
IgG (Sigma-Aldrich, http://www.sigmaaldrich.com) diluted in
0.5% blotto with 2.5% fetal calf serum. Antigenemia was
expressed as the EIA (OD)450 nm value of each sample31,000.
The mean OD value plus two standard deviations was
calculated from OD values obtained from the sera of children
with noninfectious, nonchronic conditions, and healthy adults
and used as a cut-off value. A sample with an OD above the
cut-off value was considered positive. All samples were coded,
analyzed by EIA, and decoded after testing. Sera were analyzed
for antirotavirus IgA and IgG antibody using a standardized
YO (P[8]G3) strain human rotavirus as antigen as described
earlier [29,30]. An antibody response was deﬁned as a 4-fold
rise in antibody titer and/or a conversion from negative to
positive in an acute/convalescent serum pair. Validation of
serum antibody testing was established by utilization of the
same antigen preparation and by interspersion of 30 sera of
known titer tested previously in establishment of an immune
correlate for protection against rotavirus infection [29,30]. P-
and G-typing was performed as described [31–33].
Determination of Viremia
Infectious virus from human serum was propagated in HT-
29 cells using a modiﬁcation of the method in Superti et al.
[34]. To amplify potentially infectious virus, serum samples
from the active, prospective case-surveillance study were
serially passaged three to ﬁve times in HT-29 cells as
previously described [35]. Serial 2-fold dilutions of serum
from 1:20 to 1:160 or 1:20 to 1:2560 were tested in each
passage. The presence of infectious virus from the passaged
samples was assessed by ﬂuorescent focus assay and detected
with either a polyclonal antibody generated against whole
virus (rabbit anti-ALA) or the nonstructural protein NSP4
114–135 peptide antibody [36] as previously described [37].
Both antibodies are broadly reactive and recognize multiple
animal and human strains of rotavirus ([38] and unpublished
data). Fluorescent cells were imaged using an Olympus IX70
inverted ﬂuorescent microscope (http://www.olympusamerica.
com). Cells were scored by an observer blinded to the study
design. If positive cells were observed at any dilution, the
serum was considered positive for infectious virus. Several
approaches were utilized to (1) reduce the likelihood of and
(2) provide detection of cross contamination during the
multiple blind passages. All passages were performed in
laminar ﬂow hood. Blank wells and wells with sera from
children with noninfectious, nonchronic conditions were
always ﬂuorescent negative despite being interspersed be-
tween positive wells containing antigen positive sera. A total
of six positive and four negative samples were serially
passaged in two independent series of experiments starting
with the original sera. The presence or absence of infectious
virus in the sera in the replicate experiment was exactly the
same as the initial result. The pattern of staining, the integrity
of the monolayer, and the growth kinetics over several
passages was consistent with a virus adapting to tissue culture
and not that of a previously adapted laboratory strain.
Statistical Analysis
OD values for patients in different groups were compared
by ANOVA. When Bartlett’s test indicated variances of
groups signiﬁcantly differed, the nonparametric Kruskal-
Wallis H test value was taken. Serum OD values were scored
as positive or negative as described above. Regression was
used to test the positive or negative association of the OD
values among positive sera with continuous variables or by
logistic regression with binomial variables. p , 0.05 was
considered signiﬁcant. Statistical analyses were conducted in
Epi Info, version 6.0 [39].
Results
Rotavirus Antigenemia Does Not Depend upon Excretion
of Rotavirus in the Stool or the Clinical Manifestation of
Diarrhea
The most common clinical manifestation of rotavirus
infection is dehydrating diarrhea. Antigenemia occurs in
children with rotavirus diarrhea [19–21], but it is unknown
whether diarrhea is a necessary correlate for antigenemia. To
investigate this question, we obtained sera and stools from 98
children with gastroenteritis. Of the 57 children whose stool
was rotavirus-positive, rotavirus antigenemia was detected in
51 (90%) (Figure 1A). Antigenemia was not observed in any
serum collected from either set of controls: children with
noninfectious, nonchronic conditions (0/17) or healthy adults
(0/28). The mean OD value (p ¼ 0.001) and the rate of
antigenemia (p ¼ 0.001) in the rotavirus-positive stool group
were both signiﬁcantly higher than those of the healthy
group.
Of the 41 children with gastroenteritis and rotavirus-
negative stools, ﬁve (12%) had rotavirus antigenemia (Figure
1A). All ﬁve with antigenemia also had diarrhea. Although the
mean OD (p ¼ 0.001) and rate (p ¼ 0.001) were signiﬁcantly
lower than that of the rotavirus-positive stool group (Figure
1A), the mean OD (p ¼ 0.67) and rate (p ¼ 0.17) were not
signiﬁcantly higher than the rate of 0% among children with
noninfectious, nonchronic conditions. From these ﬁve
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positive for antigenemia, acute and convalescent sera were
available from two children to test for rotavirus-speciﬁc
antibodies by EIA. Both children had a greater than 4-fold
increase in rotavirus-speciﬁc antibody titers from acute to
convalescent samples (boxes, Figure 1B), indicating that at
least two of these ﬁve children had rotavirus infections
undiagnosed by stool testing.
Children with gastroenteritis were further stratiﬁed upon
t h eb a s i so ft h ep r e s e n c eo ra b s e n c eo ft h ec l i n i c a l
manifestation of diarrhea. A comparable high mean OD (p
¼ 0.88) and rate (p ¼ 1.00) of antigenemia was observed in
serum from children with rotavirus-positive stool and
diarrhea (43/48; 90%), and in children with rotavirus-positive
stool without diarrhea (8/9; 89%; Figure 1B). For comparison,
there was a signiﬁcant difference in mean OD (p¼0.001) and
antigenemia rate (p ¼ 0.001) in children with rotavirus-
positive stools without diarrhea compared to children with
noninfectious, nonchronic conditions (Figure 1A and 1B).
Detection of Antigenemia in Ill Children without
Gastroenteritis
The ﬁnding that rotavirus antigenemia was present in the
absence of diarrhea suggested that rotavirus might be present
in other populations of ill children. To test whether children
with respiratory symptoms, but no diarrhea, might have
rotavirus antigenemia, we tested 17 serum samples from
children suffering from bronchiolitis not attributed to any of
several respiratory viruses tested (see Methods). Of these
serum samples, two were rotavirus positive (12%, data not
shown). A total of 58 serum samples tested from children with
bronchiolitis attributed to infection with a respiratory virus
were negative for rotavirus antigen (data not shown). The rate
of rotavirus antigenemia in undiagnosed bronchiolitis was
signiﬁcant compared to the rate in diagnosed bronchiolitis (p
¼0.049). As many as 66% of children with rotavirus infection
exhibit upper respiratory tract symptoms in addition to
gastroenteritis [40]. However, it is unknown whether children
with rotavirus infection have respiratory disease in the
absence of gastroenteritis. Our ﬁndings suggest that rotavirus
infection may be underdiagnosed and highlight a possible
etiologic role for rotavirus in respiratory illness in some
children.
Neither Time after Onset of Gastroenteritis Nor Age
Affected Level of Rotavirus Antigenemia Early after Onset
of Symptoms
Analysis of small numbers of samples collected from zero to
22 days after onset of diarrhea suggested that time after onset
of diarrhea can negatively affect the detection of rotavirus
antigenemia or RNA [16,19,20]. However, rotavirus is an
acute infection and generally cleared within seven to 14 days.
Most of the samples examined in Figure 1 were collected
within six days after the onset of disease, and all sera were
collected from children sufﬁciently ill to be hospitalized on
the day of serum collection. To investigate whether time
within the ﬁrst week after onset of disease affected
antigenemia, we plotted the antigenemia OD values from
the rotavirus-positive stool group (n ¼ 57) against days after
onset of gastroenteritis (Figure 2A). The correlation between
serum antigen levels and longer time after onset of gastro-
enteritis (n ¼ 5–11 values/day) was not statistically signiﬁcant
in this patient group (r ¼  0.04, f ¼ 0.14, and p ¼ 0.09).
Age at onset of illness might adversely affect detection of
antigenemia. To determine whether age was associated with
antigenemia levels, the antigenemia OD values from the
rotavirus-positive stool group were plotted against the age of
the child (between 2.5–50 mo) from whom each sample was
obtained (Figure 2B). No signiﬁcant correlation between
serum antigenemia level and age of the child was observed (r
¼ 0.03, p ¼ 0.83)
The Detection of Rotavirus Antigenemia Negatively
Correlates with Acute Antibody Titers
Children with low rotavirus-speciﬁc serum IgG titers have
been shown to have higher levels of rotavirus antigen in their
serum [20], suggesting that serum antibodies inﬂuence the
ability to detect antigenemia. We tested whether higher levels
Figure 1. Rotavirus Antigenemia in Children Does Not Depend on the
Presence of Diarrhea
(A) Sera obtained from children with noninfectious, nonchronic
conditions (n ¼ 17), healthy adults (n ¼ 28), children with gastroenteritis
but rotavirus stool negative (n ¼ 41), and children with gastroenteritis
that were rotavirus stool positive (n ¼ 57) were diluted 1:10 and tested
for rotavirus antigen by EIA. Values for each sample were recorded as OD
3 1,000. The cut-off value for positive samples (line) was established by
calculating two standard deviations above the mean OD value of the
children with noninfectious, nonchronic conditions and healthy adults.
Numbers indicate mean OD values 6 standard deviation. *p ¼ 0.001
compared to children with noninfectious, nonchronic conditions.
(B) Children with gastroenteritis (n ¼ 98) with or without rotavirus
present in the stool were further stratified on the basis of criteria of the
presence or absence of diarrhea. Numbers indicate mean OD values 6
standard deviation. Boxes indicate children from whom serum samples
were analyzed for increases in antibody titers between acute and
convalescent samples.
#p ¼ 0.001 compared to rotavirus (RV) Neg No
Diarrhea group.
þp¼0.88 compared to rotavirus Pos No Diarrhea group.
doi:10.1371/journal.pmed.0040121.g001
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resulted in a lower antigenemia OD value. There was a
signiﬁcant negative correlation between the OD value from
the EIA to detect antigenemia and IgA titers (n¼39 samples, r
¼  0.44) (95% conﬁdence interval  0.66 to  0.15; p ¼ 0.002)
and IgG (n ¼ 39 samples, r ¼  0.40) (95% conﬁdence interval
 0.63 to  0.11; p ¼ 0.007) titers. There was no correlation
between convalescent antirotavirus IgG and IgA titers and the
presence of rotavirus antigenemia. Comparison of acute
rotavirus-speciﬁc IgA and IgG levels between rotavirus-
negative children with diarrhea to those of the rotavirus-
positive children with diarrhea found no statistically signiﬁ-
cant trend of higher acute antibody levels in the children
without rotavirus, (p ¼ 0.12 and p ¼ 0.19, respectively).
However, inclusion of the acute rotavirus-speciﬁc antibody
titers of the rotavirus-negative children to the correlation
analysis still resulted in a clear negative correlation between
acute IgA (n¼75 samples, r¼ 0.33) (95% conﬁdence interval
 0.52 to  0.11) or IgG titer (n ¼ 75 samples, r ¼  0.37) (95%
conﬁdence interval  0.55 to  0.16) and antigenemia.
There are two possible explanations for the inverse
correlation between antigenemia detection and the level of
serum antibodies: (1) serum antibody prevents antigenemia
or (2) serum antibody is bound to rotavirus antigens present
in the blood, preventing detection of the antigens by EIA.
Further analysis will be necessary to determine if stool
rotavirus-positive children with low or undetectable levels of
antigenemia have rotavirus antibody-antigen complexes
present in the circulation.
Rotavirus Strain Does Not Influence Antigenemia
The high rate of antigenemia in children (Figure 1) suggests
that antigenemia is not restricted to a speciﬁc strain or
serotype of rotavirus. To test this hypothesis, the P and G
genotypes of the virus in the stool were typed using reverse
transcriptase-PCR (Table 1). Several children had mixed
infections based on detection of multiple genotypes. Analysis
of variance among serum antigenemia values by either G or P
type indicated no signiﬁcant association between type of the
virus and antigenemia (p ¼ 0.96 and p ¼ 0.78, respectively).
This lack of association between antigenemia and viral G or P
type suggests that antigenemia is not a property of a viral type.
Detection of Infectious Virus in Rotavirus-Positive Sera
Reports of the detection of RNA in the blood of children
infected with rotavirus [10,16,19,20,22,41] suggest, but do not
prove, that intact infectious virions are present. To test
whether detection of antigenemia in serum implied that
infectious virus was present, serum aliquots were diluted 1:20
to 1:160 and subjected to three to ﬁve serial blind passages in
human colon adenocarcinoma cells (HT-29), followed by a
ﬂuorescent focus assay (Figure 3). Sera were diluted, (1)
because of the expectation that the presence of serum
inhibitors of viral replication [42,43] would inhibit detection
of virus in undiluted or low dilutions of sera, and (2) to
provide an indication of virus titer in the original sera.
Fluorescent foci indicative of infectious virus were observed
at either a 1:80 or 1:160 dilution in 11/11 (100%) sera from
serum antigen-positive children and in two out of nine (22%)
sera from serum antigen-negative individuals (Table 2). The
two children with viremia from the latter group were positive
for stool rotavirus. Statistical analysis indicated that anti-
genemia was predictive of viremia in children (p ¼ 0.002,
Yates’ corrected v
2). A subset of sera (Table 2) was analyzed at
additional dilutions, 1:320 to 1:2,560, and serially passaged.
Although we were unable to determine virus titers directly
from the blood, limiting dilution analyses showed infectious
virus at a maximal dilution of 1:160.
Figure 2. Detection of Rotavirus Antigenemia within Eight Days after
Onset of Symptoms Does Not Depend on the Number of Days after
Onset of Illness or the Age of Child
The ODs of serum samples obtained from children with rotavirus-positive
stools were plotted against days after onset of illness (A) or age of child
in months (B). Correlation analysis was performed (line) and R
2 values
calculated.
doi:10.1371/journal.pmed.0040121.g002
Table 1. Distribution of P and G Genotypes in Rotavirus-Positive
Stools
P Type G Type
1 1,2
a 2 3 4 9 NT Total
4 5 14 19
4,8
a 52 11 9
61 1 1 3
6,8
a 33
81 2 1 2 1 1 6
90 1 1
N T 31 11 6
Total 29 4 17 3 1 2 1 57
P- and G-typing was performed using reverse transcriptase-PCR as described [31–33].
aBoth genotypes were present in the sample.
NT, nontypeable.
doi:10.1371/journal.pmed.0040121.t001
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Rotavirus infection in children results in antigenemia
[19,20]. Although RNA has been associated with antigenemia
[20], proof of viremia in children has not been previously
demonstrated. Here, we present proof that antigenemia is
associated with infectious virus in rotavirus-infected children.
Major technical barriers to the isolation of infectious wild-
type human rotavirus from serum are that human primary
isolates require adaptation to grow in vitro [34] and that
serum factors can inhibit viral replication [42,43]. Attempts
to isolate human rotavirus from serum were unsuccessful
using MA104 cells [20]. Our detection of infectious virus in
serum may have been greatly enhanced by the use of HT-29
cells [34], serial blind passage, and testing multiple dilutions
of sera. The detection of infectious virus in the serum from
rotavirus-infected children indicates that rotavirus is present
Figure 3. Infectious Rotavirus Is Present in Children with Rotavirus Antigenemia
A total of 11 antigen-positive and nine antigen-negative sera were examined for infectious virus by focus-forming assay after three blind serial passes in
HT-29 cells. Infected HT-29 cells were identified using a rabbit antiserum against the ALA strain of rotavirus (A–F) or against NSP4 peptide 114–135 (G,
H) followed by a FITC-labeled secondary antibody. Shown are: (A) Rhesus rotavirus (RRV) as a positive control; (B, G) Antigen negative serum; and (C–F,
H) antigen positive serum.
doi:10.1371/journal.pmed.0040121.g003
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infection. In addition, antigenemia is predictive of viremia
and can be used as a marker for the presence of extra-
intestinal rotavirus.
The possible clinical consequences of viremia in humans
are not yet known. During viremia, infectious rotavirus would
gain access to most tissues and cell types in the body. Indeed,
rotavirus proteins or RNA have been detected in endothelial
cells [14,15], liver [22], central nervous system and cerebro-
spinal ﬂuid [12,14], and kidney [22] from infected children.
The detection of infectious virus in serum suggests that one
possible mechanism of how virus reaches these sites involves a
viremic dissemination of rotavirus extraintestinally.
Here, we observed an antigenemia rate of ;90% in samples
obtained from children with rotavirus diarrhea, which is
substantially higher than previous reports (43% [20], 63%
[21], and 67% [19]). The differences in rates observed among
the studies may be attributed to differences in duration of
illness prior to serum sample collection. In the current study,
all children analyzed had gastroenteritis for less than seven
days and were sufﬁciently ill to be hospitalized on the day of
serum collection. As one might expect in an acute viral
infection, the rates of antigenemia are greater when serum
from children with diarrhea less than eight days are included,
and as duration of illness increased, the likelihood of
antigenemia detection decreased [19,20]. Antigenemia was
also less likely to be detected in children with higher serum
antibody titers [20]. Therefore, based upon the current results
and studies in animal models of rotavirus infection
[19,24,38,44], we suspect that close to 100% of children with
rotavirus infection exhibit antigenemia early in infection,
and the rate declines over time as acute antibody titers or
other immune effectors rise. A large prospective study
examining sera from children on speciﬁc days after the onset
of symptoms or repeated serum samplings over time from
infected children will be necessary to exactly determine the
rate of occurrence of antigenemia in relation to the onset of
symptoms and the inﬂuence of antibody titer upon detection.
These studies will also be necessary to determine whether
there is a relationship between the presence of type-speciﬁc
neutralizing antibodies and the occurrence of antigenemia.
Previously, rotavirus antigenemia was reported in children
with rotavirus-positive stools and diarrhea [19–21]. Because
previous studies examined antigenemia in children with
diarrhea, it was not known if diarrhea was necessary for
antigenemia. We found that antigenemia occurred in eight
out of nine rotavirus-positive children in the absence of
diarrhea (Figure 1B). Because of this ﬁnding and the
association of rotavirus infection with respiratory disease
[40,45–47], we tested whether rotavirus antigenemia was
p r e s e n ti nc h i l d r e nw i t hn o n g a s t r o i n t e s t i n a li l l n e s sb y
examining children with bronchiolitis for antigenemia. We
found two out of 17 serum samples were rotavirus-antigen
positive. This ﬁnding may be incidental, or alternatively it
may support previous associations of rotavirus infection with
respiratory disease and indicate that diarrhea may not be the
sole clinical manifestation associated with rotavirus antige-
nemia/viremia. In fact, studies in animal models indicate that
viremia occurs in the absence of diarrhea [19,24] and that
infectious virus is present within the respiratory tract
[23,38,44].
We also observed an antigenemia rate of 12% in children
with diarrhea but with rotavirus-negative stools. There are
several possible explanations for this ﬁnding, including
discordance between the kinetics of stool and sera anti-
genemia, a false-negative stool result, the occurrence of
rotavirus disease in the absence of detectable stool antigen
excretion (by current assays), or a false positive antigenemia
result. The latter is unlikely because rotavirus infection was
conﬁrmed by a greater than 4-fold rise in convalescent
antibody titer [29,48], as well as the fact that neither
seroconversion nor antigenemia was detected in either serum
from children with noninfectious, nonchronic conditions or
healthy adults. These ﬁndings conﬁrm previous suggestions
[19,20] that testing serum for rotavirus antigen may be an
alternate approach to diagnose rotavirus infection.
Our data suggest that most children infected with rotavirus
develop viremia, but it does not appear that systemic
infection routinely causes clinically signiﬁcant nongastroin-
testinal disease. It is more probable that rotavirus viremia
results in subclinical extraintestinal infection that in some
cases, may progress to clinical diseases. This hypothesis may
explain the broad array of diseases associated with rotavirus
infection, including biliary atresia, pneumonia, disseminated
intravascular coagulation, and Reye’s syndrome. Alternatively,
because rotavirus is such a common infection, these associ-
ations may have been coincidental. However, the ﬁnding that
rotavirus commonly causes viremia suggests a re-evaluation of
the association of rotavirus with other nonintestinal diseases
is warranted. Because the number of children infected with
rotavirus each year is over 114 million [1], even a small
percentage of these children experiencing serious clinical
extraintestinal disease would mean a relatively large number
Table 2. Rotavirus Viremia in Children with Antigenemia
Sample Stool
Rotavirus
Genotype Diarrhea Antigen-
emia
a
Infectious
Virus
1
b  þ 0  
2
b  þ 0  
3
b    14  
4
c NA
d   14  
5
c NA
d   15  
6  þ 34  
7
b    72  
8
b þ P[8], G1 þ 0 þ
9 þ P[4], G1   53 þ
10 þ P[8], G1 þ 1,447 þ
11 þ P[4],P[8], G1 þ 1,642 þ
12
b  þ 1,979 þ
13 þ P[4], G2 þ 1,996 þ
14
b  þ 2,054 þ
15
b þ P?, G3   2,176 þ
16 þ P?, G1 þ 2,204 þ
17
b þ P[4], G2 þ 2,333 þ
18 þ P[4],P[8], G1 þ 2,335 þ
19
b þ P?, G1   2,396 þ
20 þ P[4],P[8], G1 þ 2,564 þ
All samples tested were from the active, prospective case-surveillance study (study 1)
unless otherwise indicated.
aAntigenemia defined as OD at 450 by EIA.
bSamples that were serially blind passaged in two independent series.
cSample was from a healthy adult laboratory worker (study 2).
dSample not available for testing.
?, nontypeable.
doi:10.1371/journal.pmed.0040121.t002
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Rotavirus Viremia in Childrenof children could be affected. The discovery that rotavirus
causes viremia in children changes the way we view rotavirus
pathogenesis, and future work will need to focus upon the
impact of rotavirus viremia upon disease burden.
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Background. Rotavirus is a type of virus that is the commonest cause of
severe diarrhea among children worldwide. It is passed from one person
to another when virus present in the stool of an infected person is
swallowed by another individual. The infection causes vomiting, watery
diarrhea, and fever; many children need to be hospitalized as a result and
globally more than 600,000 children are thought to die as a result of
rotavirus infections per year. Evidence from single case descriptions of
infected children have suggested that rotavirus might also cause
symptoms outside of the gut—for example, in the lungs or brain.
Previous studies have found fragments of rotavirus, for example RNA or
parts of virus protein, in tissues outside of the gut such as liver, kidney,
blood, and heart. However, simply finding fragments such as RNA or
protein does not necessarily mean that rotavirus infects these tissues.
Why Was This Study Done? These researchers wanted to find out
whether rotavirus was present in the blood of infected children. If
evidence of rotavirus in the blood was found, this might help explain
why some children infected with rotavirus have symptoms affecting
organs other than the gut.
What Did the Researchers Do and Find? In this study, five groups of
patients were recruited and tests were done on each to find out whether
infectious rotavirus was present in their bloodstream, and also whether
the researchers could detect rotavirus components in blood using
antibodies against particular parts of the rotavirus particle. The five
groups of patients that were compared included children hospitalized
with gastroenteritis; children hospitalized with noninfectious conditions;
healthy adult laboratory workers; children with lung infections from
known viruses; and finally children with lung infections of unknown
cause. The researchers found that among the children with gastro-
enteritis who had rotavirus in their stool, 90% also had evidence of
rotavirus particles in their bloodstream. By contrast, control individuals
(either children who were hospitalized with noninfectious conditions or
healthy adults) did not have rotavirus particles in blood. A small
proportion of children with gastroenteritis but no rotavirus in their stool
did have rotavirus particles in blood. Interestingly, a small proportion of
the children who had lung infections (but in whom no known virus had
been identified as the cause) showed evidence of rotavirus in their
bloodstreams. Finally, in a group of 11 children with evidence of
rotavirus particles in their bloodstreams, all were found to also have
infectious virus present in the blood.
What Do These Findings Mean? These results show that rotavirus is
able to spread beyond the gut and into the bloodstream. The finding
that rotavirus can spread into the bloodstream may explain some earlier
suggestions that rotavirus is responsible for symptoms outside of the
gut. However, it is not yet clear how commonly children with rotavirus
have other symptoms resulting from the virus spreading into their
bloodstream.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040121.
  Read the related PLoS Medicine Perspective article by David Candy
  Information from the World Health Organization Initiative for Vaccine
Research on rotavirus disease burden; see also the Rotavirus Vaccine
Program, a partnership that aims to develop rotavirus vaccines
appropriate for use in developing countries
  Information from the US Centers for Disease Control and Prevention
about rotavirus
  Health Encyclopedia entry from the UK’s NHS Direct on Rotavirus
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